Senior insider sale
NEWAMSTERDAM PHARMA CO N.V. — senior position signals high conviction
$2.22M
72.81K shares
What this filing means
LANGE LOUIS G plans to sell 72.81K shares of NEWAMSTERDAM PHARMA CO N.V. valued at approximately $2.22M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/11/2026ACC: 0001968582-26-000272
72.81K
Shares to sell
$2.22M
Approx. market value
44.62K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Warrant Exercise
Cash
3/9/2026
44.62KTotal acquired44.62K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/9/2026 | Warrant Exercise Cash | 44.62K | — |
| Total | 44.62K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
28.19K
Market value
$828.8K
3/6/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
44.62K
Market value
$1.40M
3/11/2026
Total
Units
72.81K
Value
$2.22M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/6/2026 | 28.19K | $828.8K | — | Completed |
| Planned — Approximate Date | ||||
3/11/2026 | 44.62K | $1.40M | Nasdaq | Planned |
| Total | 72.81K | $2.22M | ||